Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications

키워드

참고문헌 (89)

1. Barati M, "Intermittent fasting : a promising dietary intervention for autoimmune diseases", Autoimmun Rev, 22, pp.103408~ (2023)
2. Betterle C, "Type 3 autoimmune polyglandular syndrome(APS-3)or type 3 multiple autoimmune syndrome(MAS-3) : an expanding galaxy", J Endocrinol Invest, 46, pp.643~665 (2023)
3. Ibáñez-Cabellos JS, "Oxidative stress and epigenetics : miRNA involvement in rare autoimmune diseases", Antioxidants, 12, pp.800~ (2023)
4. Chi X, "Innate and adaptive immune abnormalities underlying autoimmune diseases : the genetic connections", Sci China Life Sci, 66, pp.1482~1517 (2023)
5. Yao X, "LncRNA HOTTIP from synovial fibroblast-derived exosomes : a novel molecular target for rheumatoid arthritis through the miR-1908-5p", STAT3 axis, 2021, pp.409, 112943~
6. Wang HB, "Biological function and clinical potential therapeutic applications of exosomes", J Reprod Med, 30, pp.966~970 (2021)
7. Kalluri R, "The biology, function, and biomedical applications of exosomes", Science, 367, pp.eaau6977~ (2020)
8. Chung IM, "Exosomes : current use and future applications", Clin Chim Acta, 500, pp.226~232 (2020)
9. Dong C, "Circulating exosomes derived-miR-146a from systemic lupus erythematosus patients regulates senescence of mesenchymal stem cells", BioMed Res Int, 2019, pp.6071308~ (2019)
10. Perez-Hernandez J, "Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus", PLoS One, 10, pp.e0138618~ (2015)
11. Xu H, "Potential therapeutic applications of exosomes in different autoimmune diseases", Clin Immunol, 205, pp.116~124 (2019)
12. Kowal J, "Biogenesis and secretion of exosomes", Curr Opin Cell Biol, 29, pp.116~125 (2014)
13. Zhang W, "Exosomes derived from platelet-rich plasma activate YAP and promote the fibrogenic activity of Müller cells via the PI3K", Akt pathway, 2020, pp.193, 107973~
14. Fang Y, "Exosomes as biomarkers and therapeutic delivery for autoimmune diseases : opportunities and challenges", Autoimmun Rev, 22, pp.103260~ (2023)
15. Kostopoulou M, "Annals of the Rheumatic Diseases collection on lupus nephritis(2019–2022) : novel insights and advances in therapy", Ann Rheum Dis, 82, pp.729~733 (2023)
16. Perez-Hernandez J, "Extracellular vesicles as biomarkers of systemic lupus erythematosus", Dis Markers, 2015, pp.613536~ (2015)
17. Lee JY, "Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response", Arthritis Res Ther, 18, pp.264~ (2016)
18. Liu DF, "Bone marrow mesenchymal stem cell exosomes miR-10a-5p regulates systemic lupus erythematosus cells by down-regulating expression of UVRAG", Chin J Immunol, 36, pp.2142~2147 (2020)
19. Cao W, "miR-125b is downregulated in systemic lupus erythematosus patients and inhibits autophagy by targeting UVRAG", Biomed Pharmacother, 99, pp.791~797 (2018)
20. Tu J, "UC-BSCs exosomes regulate Th17", Treg balance in patients with systemic lupus erythematosus via miR-19b, Cells, pp.2022, 11[DOI]
21. Li C, "Analysis on miRNA Expression Profile of Urinary Exosomes in Type IV LN Complicated by Cellular Crescents", pp.2018
22. Huang J, "Comparison of plasma levels and immunoactivities of different forms of circulating-free DNA in systemic lupus erythematosus patients", Xibao Yu Fenzi Mianyixue Zazhi, 37, pp.633~640 (2021)
23. Xu Y, "Study on the differential expression of circular rna in serum exosomes of patients with SLE", J Hubei Univ Sci Technol Med Ed, 36, pp.129~133 (2022)
24. Xu JN, "Expression and Its Significance of MicroRNAs in Plasma Exosomes of Patients With Systemic Lupus Erythematosus", pp.2022
25. Chen J, "Novel isatin-based hybrids as potential anti-rheumatoid arthritis drug candidates : synthesis and biological evaluation", Bioorg Chem, 128, pp.106063~ (2022)
26. Li Z, "Emerging role of exosomes in the joint diseases", Cell Physiol Biochem, 47, pp.2008~2017 (2018)
27. Wang L, "Circulating exosomal miR-17 inhibits the induction of regulatory T cells via suppressing TGFBR II expression in rheumatoid arthritis", Cell Physiol Biochem, 50, pp.1754~1763 (2018)
28. Ren Z, "Genetically engineered exosomes as a potential regulator of Th1 cells response in rheumatoid arthritis", Biopreserv Biobank, 21, pp.355~366 (2023)
29. Hu Q, "Clinical applications of exosome membrane proteins", Precis Clin Med, 3, pp.54~66 (2020)
30. Ren J, "Exosomal long non-coding RNA TRAFD1-4 : 1 derived from fibroblast-like synoviocytes suppresses chondrocyte proliferation and migration by degrading cartilage extracellular matrix in rheumatoid arthritis", Exp Cell Res, 422, pp.113441~ (2023)
31. Chen J, "Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1", BMP, Biomater Sci, pp.2020, 8[DOI]
32. Edhayan G, "Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis", Arthritis Res Ther, 18, pp.87~ (2016)
33. Zhang L, "Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment", Bioact Mater, 18, pp.1~14 (2022)
34. Chen Z, "Therapeutic potential of mesenchymal cell-derived mirna-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF", J Immunol, 201, pp.2472~2482 (2018)
35. Mi L, "Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis", Int Immunopharmacol, 127, pp.111365~ (2024)
36. Lee HI, "Exosome-mediated delivery of super-repressor IκBα alleviates inflammation and joint damages in rheumatoid arthritis", Arthritis Res Ther, 26, pp.2~ (2024)
37. Li H, "M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization", J Control Release, 341, pp.16~30 (2022)
38. Vargas-Uricoechea H, "Molecular mechanisms in autoimmune thyroid disease", Cells, 12, pp.918~ (2023)
39. Zhao N, "MicroRNA-326 Participates in Autoimmune Thyroiditis by Regulating Th17 Cells", pp.2019
40. Cui XJ, "Study on Exosome-Induced T Lymphocyte Imbalance in The Pathogenesis of Autoimmune Thyroiditis", pp.2020
41. Cui X, "Circulating exosomes activate dendritic cells and induce unbalanced CD4+ T cell differentiation in Hashimoto thyroiditis", J Clin Endocrinol Metab, 104, pp.4607~4618 (2019)
42. Huang MS, "Circulating Exosomes From Patients With Graves Disease Induce an Proinflammatory Immune Response via Toll-Like Receptor", pp.2019
43. Hiratsuka I, "Circulating microRNAs in graves’ disease in relation to clinical activity", Thyroid, 26, pp.1431~1440 (2016)
44. Sun Y, "Microarray profiling and functional analysis of differentially expressed plasma exosomal circular RNAs in Graves’ disease", Biol Res, 53, pp.32~ (2020)
45. Ridgewell D, "Sjögren’s syndrome : shedding light on emerging and key drug targets", Expert Opin Ther Targets, 26, pp.869~882 (2022)
46. André F, "Sjögren’s syndrome", J Dtsch Dermatol Ges, 20, pp.980~1002 (2022)
47. Kapsogeorgou EK, "Salivary gland epithelial cell exosomes : a source of autoantigenic ribonucleoproteins", Arthritis Rheum, 52, pp.1517~1521 (2005)
48. Cortes-Troncoso J, "T cell exosome-derived miR-142-3p impairs glandular cell function in Sjögren’s syndrome", JCI Insight, 5, pp.e133497~ (2020)
49. Gallo A, "Targeting the Ca(2+)sensor STIM1 by exosomal transfer of ebv-miR-BART13-3p is associated with Sjögren’s syndrome", EBioMedicine, 10, pp.216~226 (2016)
50. Li B, "Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren’s syndrome by modulating the balance of Treg and Th17 cells", Stem Cell Res Ther, 12, pp.478~ (2021)
51. Du Z, "SHED-derived exosomes ameliorate hyposalivation caused by Sjögren’s syndrome via Akt", GSK-3β, Chin Med J(Engl), pp.2023, 136[DOI]
52. Lei LY, "Role of Tfh cells in pathogenesis of primary Sjogren’s syndrome", Chin J Immunol, 30, pp.392~399 (2014)
53. Saito M, "Unique phenotypes and functions of follicular helper T cells and regulatory T cells in Sjögren’s syndrome", Curr Rheumatol Rev, 14, pp.239~245 (2018)
54. Ma D, "Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4+ T cells in patients with primary Sjögren’s syndrome", Inflammopharmacology, 31, pp.1823~1838 (2023)
55. Xu HY, "The expression of plasma exosomal miR-1224-5p in myasthenia gravis and its diagnostic value as a biomarker", Chin J Neuroimmunol Neurol, 26, pp.172~178 (2019)
56. Li MX, "Preliminary study on microRNA expression profile of plasma exosomes in patients with myasthenia gravis", Chin J Immunol, 36, pp.3010~3014 (2020)
57. Liang DY, "A Preliminary Study of Plasma Exosomal miR-1273f as a Marker for Diagnosis of Systemic Myasthenia Gravis", pp.2018
58. Xu HY, "Plasma Exosomal MiR-106a-5p : A New Potential Biomarker for Myasthenia Gravis", pp.2019
59. Xu H, "Plasma exosomal miR-106a-5p expression in myasthenia gravis", Muscle Nerve, 61, pp.401~407 (2020)
60. Yin W, "Immature exosomes derived from microrna-146a overexpressing dendritic cells act as antigen-specific therapy for myasthenia gravis", Inflammation, 40, pp.1460~1473 (2017)
61. Lu W, "Expression profiling and bioinformatics analysis of exosomal long noncoding RNAs in patients with myasthenia gravis by RNA sequencing", J Clin Lab Anal, 35, pp.e23722~ (2021)
62. Zhong H, "Low-dose rituximab lowers serum exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients", J Neuroimmunol, 348, pp.577383~ (2020)
63. Liu X, "Role of exosomes in muscle development and its research advances", Hubei Agr Sci, 60, pp.54~57 (2021)
64. Zhang QY, "Skeletal muscle derived-exosome promotes proliferation and inhibits differentiation of muscle stem cells", Chin J Cell Biol, 40, pp.1171~1178 (2018)
65. Zhou B, "Preliminary Study on the Mechanism of Mesenchymal Stem Cell Exosome-Derived miR-25 in the Treatment of Type 1 Diabetes in Mice", pp.2020
66. Sabry D, "The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats", Biotechnol Lett, 42, pp.1597~1610 (2020)
67. Zhang L, "Proteomic analysis of plasma exosome protein in patients with type 1 diabetes mellitus", Int J Lab Med, 41, pp.588~591 (2020)
68. Qian XL, "Exosomes Derived From TNF-a Treated HUC-MSCs Treat Type 1 Diabetes by Immunosuppression", pp.2021
69. Chang W, "Exosomes and their noncoding RNA cargo are emerging as new modulators for diabetes mellitus", Cells, 8, pp.853~ (2019)
70. Pang H, "Characterization of lncRNA profiles of plasma-derived exosomes from type 1 diabetes mellitus", Front Endocrinol(Lausanne), 13, pp.822221~ (2022)
71. Liu Y, "A genome-wide analysis of long noncoding RNAs in circulating leukocytes and their differential expression in type 1 diabetes patients", J Diabetes Res, 2020, pp.9010314~ (2020)
72. Geng G, "Identification of a multi-long noncoding RNA signature for the diagnosis of type 1 diabetes mellitus", Front Bioeng Biotechnol, 8, pp.553~ (2020)
73. Wang J, "Current situation and the trend of clinical trials of drugs for treatment of multiple sclerosis", Chin J Mod Appl Pharm, 39, pp.2405~2411 (2022)
74. Galazka G, "Multiple sclerosis : serum-derived exosomes express myelin proteins", Mult Scler, 24, pp.449~458 (2018)
75. Zhang J, "Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system", Exp Neurol, 347, pp.113895~ (2022)
76. Li Z, "Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia", Int Immunopharmacol, 67, pp.268~280 (2019)
77. Wang J, "Exosomal miR-23b-3p from bone mesenchymal stem cells alleviates experimental autoimmune encephalomyelitis by inhibiting microglial pyroptosis", Exp Neurol, 363, pp.114374~ (2023)
78. Fan J, "Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2", Biomed Pharmacother, 162, pp.114593~ (2023)
79. Ebrahimkhani S, "Exosomal microRNA signatures in multiple sclerosis reflect disease status", Sci Rep, 7, pp.14293~ (2017)
80. Xiao Y, "Targeting central nervous system extracellular vesicles enhanced triiodothyronine remyelination effect on experimental autoimmune encephalomyelitis", Bioact Mater, 9, pp.373~384 (2021)
81. Pan XL, "Research progress of traditional Chinese medicine combined with stem cells in treatment of multiple sclerosis", Chin Arch Tradit Chin Med, 41, pp.155~160 (2023)
82. Guay C, "Lymphocyte-derived exosomal microRNAs promote pancreatic β cell death and may contribute to type 1 diabetes development", Cell Metab, 29, pp.348~361 (2019)
83. Wu LF, "Identification of novel rheumatoid arthritis-associated MiRNA-204-5p from plasma exosomes", Exp Mol Med, 54, pp.334~345 (2022)
84. Riazifar M, "Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders", ACS Nano, 13, pp.6670~6688 (2019)
85. Rui K, "Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells", Cell Mol Immunol, 18, pp.440~451 (2021)
86. Zhang Y, "Bone marrow mesenchymal stem cells-derived exosomes suppress miRNA-5189-3p to increase fibroblast-like synoviocyte apoptosis via the BATF2", JAK2, Bioengineered, pp.2022, 13[DOI]
87. García-Díaz DF, "Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile : relationship with autoimmunity and inflammatory markers", Arch Endocrinol Metab, 62, pp.34~40 (2018)
88. Ma W, "miR-205-5p in exosomes divided from chondrogenic mesenchymal stem cells alleviated rheumatoid arthritis via regulating MDM2 in fibroblast-like synoviocytes", J Musculoskelet Neuronal Interact, 22, pp.132~141 (2022)
89. Huang Y, "Exosomal microRNA-140-3p from human umbilical cord mesenchymal stem cells attenuates joint injury of rats with rheumatoid arthritis by silencing SGK1", Mol Med, 28, pp.36~ (2022)

관련 논문AI추천